Grading in soft tissue tumors: Principles and problems

Skeletal Radiology

Volumn 30, Issue 10, 2001, Pages 543-559

  Oliveira, A M ^a   Nascimento, A G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Grading; Prognosis; Sarcoma; Soft tissue; Survival

Indexed keywords

CANCER CENTER; CANCER GRADING; CANCER SURVIVAL; CLINICAL FEATURE; CYTOGENETICS; DATA ANALYSIS; DATA BASE; DIAGNOSTIC IMAGING; HISTOPATHOLOGY; MEDICAL ASSESSMENT; MEDICAL TECHNOLOGY; MOLECULAR GENETICS; MORPHOLOGY; MORPHOMETRICS; ORGANIZATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; REVIEW; SCORING SYSTEM; SOFT TISSUE TUMOR; STANDARDIZATION; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGE FACTORS; BIOPSY, NEEDLE; CHILD; CHILD, PRESCHOOL; DATA INTERPRETATION, STATISTICAL; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; LEIOMYOSARCOMA; LIPOSARCOMA; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RHABDOMYOSARCOMA; RISK; SARCOMA; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0034793309     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002560100408     Document Type: Review

References (171)

1. A clinical and pathological staging system for soft tissue sarcomas
2. A system for the surgical staging of musculoskeletal sarcoma
3. A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors
4. The grading of soft tissue sarcomas: Results of a clinicohistopathologic correlation in a series of 163 cases
5. Soft-tissue sarcomas of adults: Study of pathological prognostic variables and definition of a histopathological grading system
6. Prognostic factors in soft tissue sarcoma
7. The histological grading of neoplasms
8. Pathological features of soft tissue fibrosarcoma with special reference to the grade of its malignancy
9. Squamous-cell epithelioma of the lip: A study of five hundred and thirty-seven cases
10. Epithelioma of the genito-urinary organs
11. Epithelioma of cavities and internal organs of the head and neck
12. Fibrosarcoma - A clinico-pathologic and statistical study of 199 tumors of the soft tissues of the extremities and trunk
13. Sarcoma of soft tissue: Clinical and histopathologic parameters and response to treatment
14. AJCC Cancer Staging Manual
15. The effect of the anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh
16. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma
17. Histopathologic grading in spindle cell soft tissue sarcomas
18. The grading of soft tissue sarcomas
19. Grading of soft tissue sarcomas: Necrosis as a determinant of survival
20. Prognostic factors in soft tissue sarcomas: A multivariate analysis of 109 cases
21. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma
22. The risk of determining risk with multivariable models
23. Histopathological grading in soft-tissue tumours: Relation to survival in 261 surgically treated patients
24. Mitotic activity in the tissue of dead mice, and in tissues kept in physiological salt solutions
25. Mitotic activity and delay in fixation of tumour tissue: The influence of delay in fixation on mitotic activity of a human osteogenic sarcoma grown in athymic nude mice
26. Does delay in fixation affect the number of mitotic figures in processed tissue?
27. Changes in mitotic rate and cell cycle fractions caused by delayed fixation
28. Histopathological grading of soft tissue tumours: Prognostic significance in a prospective study of 278 consecutive cases
29. Prognostic significance of histologic parameters of soft tissue sarcomas
30. Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas
31. Grading of soft tissue sarcomas: Experience of the EORTC Soft Tissue and Bone Sarcoma Group
32. Classification and grading of soft-tissue sarcomas
33. Soft tissue sarcoma: Epidemiology and prognosis in 508 patients
34. The diagnosis and prognosis of soft tissue tumors
35. Multivariate analysis for histologic prognostic factors in soft tissue sarcomas
36. Prognosis for soft-tissue sarcoma in the locomotor system: A retrospective population-based follow-up study of 237 patients
37. Survival in soft tissue sarcoma: Prognostic variables identified by multivariate analysis
38. Prognostication in soft tissue sarcoma: A model with four risk factors
39. Nonrhabdomyosarcomatous soft tissue sarcomas of childhood: Formulation of a simplified system for grading
40. Pediatric nonrhabdomyosarcomas of the extremities: Influence of size, invasiveness, and grade on outcome
41. Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: An analysis of 121 patients treated at St Jude Children's Research Hospital
42. Fibrosarcoma of the soft tissues: A clinicopathologic study
43. Extremity soft tissue sarcomas: Analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher-grade sarcomas
44. Histologic grading in soft-tissue sarcomas: An analysis of 194 cases including AgNOR count and mast-cell count
45. Mitosis counting - A need for reappraisal
46. Mitosis counting in tumors
47. Mitosis counts: Reproducibility and significance in grading of malignancy
48. Histopathologists, malignancies, and undefined high-power fields
49. Grading of soft tissue sarcomas: Proposal for a reproducible, albeit limited scheme
50. Classification and grading of soft-tissue sarcomas: A comment
51. Proportion of necrosis in transplanted murine adenocarcinomas and its relationship to tumor growth
52. 2
53. Rates of growth of human solid neoplasms: I
54. Rates of growth of human neoplasms: II
55. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes
56. The killer and the executioner: How apoptosis controls malignancy
57. The hallmarks of cancer
58. Angiogenesis in cancer, vascular, rheumatoid and other disease
59. Mechanisms of angiogenesis
60. Significance of tumor-host interactions in cancer growth and metastases
61. Comparison between a 2- and 3-grade system in predicting metastatic-free survival in extremity soft-tissue sarcoma
62. Soft-tissue sarcoma: Mayo Clinic experience
63. Neoadjuvant chemotherapy and radiotherapy in the multidisciplinary management of soft tissue sarcomas of the extremity
64. Chemotherapy for adult soft tissue sarcoma. Does it work?
65. Necrosis observed on CT enhancement is of prognostic value in soft tissue sarcoma
66. Some reflections on the history and presence of quantitative pathology
67. Unbiased stereologic techniques for practical use in diagnostic histopathology
68. 3D reconstruction and quantitation of pathological tissues
69. DNA flow analysis of soft tissue tumors
70. Evaluation of newer prognostic markers for adult soft tissue sarcomas
71. The use of flow cytometry as a diagnostic aid in the management of soft-tissue tumors
72. DNA content prognostic in soft tissue sarcoma: 102 patients followed for 1-10 years
73. The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors
74. DNA ploidy of spindle cell soft-tissue tumors and its relationship to histology and clinical outcome
75. S-phase fraction of 155 soft tissue sarcomas: Correlation with clinical outcome
76. Prognostic significance of argyrophilic nucleolar organizer staining in soft-tissue sarcomas
77. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas
78. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas
79. MIB-1 expression and iododeoxyuridine labelling in soft tissue sarcomas: An immunohistochemical study including correlations with p53, bcl-2 and histological characteristics
80. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: A retrospective 216 soft tissue sarcomas
81. Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma
82. p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: A ten-year follow-up study
83. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas
84. Mutant p53 expression: A marker of diminished survival in well-differentiated soft tissue sarcoma
85. High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities
86. Altered expression of the retinoblastoma gene product in human sarcomas
87. Significance of retinoblastoma and mdm2 gene expression as prognostic markers for soft-tissue sarcoma
88. Amplification of a gene encoding a p53-associated protein in human sarcomas
89. Prognostic relevance of C-terminal Mdm2 detection is enhanced by p53 positivity in soft tissue sarcomas
90. C-myc oncogene amplification and cytometric DNA ploidy pattern as prognostic factors in musculoskeletal neoplasms
91. Clinicopathologic correlations and short-term prognosis in musculoskeletal sarcoma with c-myc oncogene amplification
92. Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: An immunohistochemical and in situ hybridization study
93. Immunohistochemical detection of bcl-2 and p53 proteins and apoptosis in soft tissue sarcoma: Their correlations with prognosis
94. Molecular determinants of soft tissue sarcoma proliferation
95. Immunohistochemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood
96. P-glycoprotein in human sarcoma: Evidence for multidrug resistance
97. Multidrug resistance phenotype in high grade soft tissue sarcoma: Correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy
98. P-glycoprotein expression in soft-tissue sarcomas
99. MDR1 gene expression: Evaluation of its use as a molecular marker for prognosis and chemotherapy of bone and soft tissue sarcomas
100. Pathology and grading of soft tissue sarcomas
101. Histologic prognostication in soft tissue sarcomas: Grading versus subtyping or both? A comprehensive review of the literature with proposed practical guidelines
102. Grading and characterization of soft tissue tumors
103. Grading of subcutaneous soft tissue tumors by means of their relationship with the superficial fascia on MR imaging
104. Magnetic resonance imaging of soft tissue tumors
105. Optimal radiologic imaging of soft tissue sarcomas
106. Bone and soft tissue tumors: The role of contrast agents for MR imaging
107. Angiography for assessment of preoperative chemotherapy in musculoskeletal sarcomas
108. Osteosarcoma: Angiographic assessment of response to preoperative chemotherapy
109. 18F]fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas
110. Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography
111. Imaging of soft-tissue tumors using L-3[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: Comparison with proliferative and mitotic activity, cellularity and vascularity
112. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas
113. Osteogenic sarcoma: Noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging
114. Multivariate statistical analysis for anatomic pathology. II. Failure time analysis
115. Modeling and variable selection in epidemiologic analysis
116. Regression models for prognostic prediction: Advantages, problems, and suggested solutions
117. Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy
118. Predicting the future: A critical appraisal of cancer prognosis studies
119. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors
120. Statistical aspects of prognostic factor studies in oncology
121. Assessment and comparison of prognostic classification schemes for survival data
122. Statistical issues in tumor marker studies
123. Survival after pulmonary metastasectomy in soft tissue sarcoma: Prognostic factors in 214 patients
124. The role of pulmonary metastasectomy for soft tissue sarcoma
125. Clinical applications of Bayesian belief networks in pathology
126. Applications of neural networks in histopathology
127. Pleomorphic malignant fibrous histiocytoma: Fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma
128. Malignant fibrous histiocytoma: Morphologic pattern or pathologic entity?
129. Myxoid variant of malignant fibrous histiocytoma
130. Malignant fibrous histiocytoma: An analysis of 200 cases
131. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: A multicenter study of 216 patients with multivariate analysis
132. Classification of rhabdomyosarcomas and related sarcomas: Pathologic aspects and proposal for a new classification - An Intergroup Rhabdomyosarcoma Study
133. Intergroup Rhabdomyosarcoma Study: Update for pathologists
134. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites: A follow-up study of 92 cases with analysis of the incidence of "dedifferentiation"
135. Well-differentiated liposarcoma: The Mayo Clinic experience with 58 cases
136. Well-differentiated liposarcoma of the retroperitoneum: A clinicopathologic analysis of 20 cases, with particular attention to the extent of low-grade dedifferentiation
137. Dedifferentiated liposarcoma: Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas
138. Dedifferentiated liposarcoma: A clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation
139. Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: Molecular and cytogenetic analysis
140. Fusion of the EWS and CHOP genes in myxoid liposarcoma
141. The clinicopathologic spectrum of myxoid and round cell liposarcoma: A study of 95 cases
142. Myxoid/round cell liposarcoma of the extremities: A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma
143. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma
144. Synovial sarcoma
145. Synovial sarcoma
146. Survival in synovial sarcoma: Multivariate study of prognostic factors with special emphasis on the comparison between early death and long-term survival
147. Synovial sarcoma: Identification of low and high risk groups
148. Soft tissue leiomyosarcoma: A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content
149. Leiomyosarcoma of soft tissue: A clinicopathologic study
150. Soft tissue fibrosarcoma: A clinicopathologic study of 132 cases
151. Malignant peripheral nerve sheath tumors: A clinicopathologic study of 120 cases
152. Angiosarcoma: A report of 67 patients and a review of the literature
153. Angiosarcoma of skin and soft tissue: A study of forty-four cases
154. Epithelioid sarcoma: A clinicopathologic review of 55 cases
155. Epithelioid sarcoma: A clinicopathologic and prognostic study of 26 cases
156. Epithelioid sarcoma. Diagnosis, prognostic indicators, and treatment
157. Clear cell tumors of the somatic soft tissues
158. Clear cell sarcoma of soft tissues: Mayo Clinic experience with 35 cases
159. Extraskeletal myxoid chondrosarcoma: An analysis of 34 cases
160. Extraskeletal myxoid chondrosarcoma: A reappraisal of its morphologic spectrum and prognostic factors based on 117 cases
161. Extraskeletal myxoid chondrosarcoma: A clinicopathologic, immunohistochemical, and ploidy analysis of 23 cases
162. Extraskeletal mesenchymal chondrosarcoma
163. Mesenchymal chondrosarcoma of bone and soft tissue: A review of 111 cases
164. Alveolar soft-part sarcoma: A review of the pathology and histogenesis
165. Alveolar soft-part sarcoma: A study of 13 typical examples and one with a histologically atypical component
166. Alveolar soft-part sarcoma: A clinico-pathologic study of half a century
167. Comparison of soft tissue Ewing's sarcoma and peripheral neuroectodermal tumor
168. Malignant peripheral neuroectodermal tumors: A retrospective analysis of 42 patients
169. Extraskeletal osteosarcoma
170. A review of 40 patients with extraskeletal osteosarcoma